Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-Mu Sun

Showing results (121-130 of 303) with videos related to

Pageof 31
Sort By:
Cancer Research and Treatment|November 19, 2016
A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell CarcinomaSung Hee Lim, Young Mog Shim, Se Hoon Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2013
Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapySeung Hwan Moon, Su-Hee Cho, Lee Chun Park, et al.
The Oncologist|May 10, 2015
Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFRMyung-Ju Ahn, Sang-We Kim, Byoung-Chul Cho, et al.
The Oncologist|May 29, 2014
Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFRMyung-Ju Ahn, Sang-We Kim, Byoung-Chul Cho, et al.
Cancer Research and Treatment|January 24, 2014
Tumor lysis syndrome in a solid tumor: a case report of a patient with invasive thymomaJi Yun Lee, Sung Hee Lim, Ji Young Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2009
Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsJong-Mu Sun, Myung-Ju Ahn, Min Jae Park, et al.
In Vivo (Athens, Greece)|May 2, 2020
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With <i>MET</i> Exon 14 SkippingJoon Young Hur, Bo Mi Ku, Joon Ho Shim, et al.
Cancer Research and Treatment|January 22, 2011
Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib EraNae Yu Kim, Jong Mu Sun, Yu-Jung Kim, et al.
Translational Lung Cancer Research|January 10, 2022
Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatmentSoohyun Hwang, Tae Hee Hong, Sehhoon Park, et al.
Clinical Lung Cancer|December 17, 2019
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional TestsSeonggyu Byeon, Boram Lee, Woong-Yang Park, et al.
Pageof 31

Showing results (121-130 of 303) with videos related to

Sort By:
Pageof 31
Cancer Research and Treatment|November 19, 2016
A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell CarcinomaSung Hee Lim, Young Mog Shim, Se Hoon Park, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2013
Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapySeung Hwan Moon, Su-Hee Cho, Lee Chun Park, et al.
The Oncologist|May 10, 2015
Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFRMyung-Ju Ahn, Sang-We Kim, Byoung-Chul Cho, et al.
The Oncologist|May 29, 2014
Phase II study of Afatinib as third-line treatment for patients in Korea with stage IIIB/IV non-small cell lung cancer harboring wild-type EGFRMyung-Ju Ahn, Sang-We Kim, Byoung-Chul Cho, et al.
Cancer Research and Treatment|January 24, 2014
Tumor lysis syndrome in a solid tumor: a case report of a patient with invasive thymomaJi Yun Lee, Sung Hee Lim, Ji Young Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2009
Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitorsJong-Mu Sun, Myung-Ju Ahn, Min Jae Park, et al.
In Vivo (Athens, Greece)|May 2, 2020
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With <i>MET</i> Exon 14 SkippingJoon Young Hur, Bo Mi Ku, Joon Ho Shim, et al.
Cancer Research and Treatment|January 22, 2011
Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib EraNae Yu Kim, Jong Mu Sun, Yu-Jung Kim, et al.
Translational Lung Cancer Research|January 10, 2022
Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatmentSoohyun Hwang, Tae Hee Hong, Sehhoon Park, et al.
Clinical Lung Cancer|December 17, 2019
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional TestsSeonggyu Byeon, Boram Lee, Woong-Yang Park, et al.
Pageof 31